A report from an organization that advocates for equity in health care ranks Georgia among the worst states for women’s health. The Commonwealth Fund says the state has several key issues to address.
Postpartum care in America leaves most facing a critical and often overlooked "fourth trimester" in isolation. Metro Detroit-based Fourth Tri Sanctuary offers support.
A prescription pill to treat postpartum depression hit the market in December, but most insurers do not yet have a policy on how patients can access it or when they will pay for it.
As many as 4 out of 5 women experience so-called “baby blues” in the weeks following birth. But postpartum depression is a psychiatric issue that often goes unrecognized.
Postpartum depression affects as many as 1 in 7 women in the U.S., though there are just two treatments approved for it. Experts say the newest could be a game-changer — depending on its price tag.
The Food and Drug Administration granted approval of the drug, Zurzuvae, for adults experiencing severe depression related to childbirth or pregnancy. The pill is taken once a day for 14 days.
More than half of these deaths occur well after the mom leaves the hospital. To save lives, mothers need more support in the "fourth trimester, that time after the baby is born," one researcher says.
To get a new drug for postpartum depression, some insurers want women to try other drugs first and even electroconvulsive therapy. It could be a test for California's new mental health parity law.
